世界の好酸球性喘息治療薬市場予測2023-2029:点滴静注型、皮下注射型

【英語タイトル】Eosinophilic Asthma Treatment Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23FB2472)・商品コード:MMG23FB2472
・発行会社(調査会社):Market Monitor Global
・発行日:2023年2月
・ページ数:62
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の好酸球性喘息治療薬市場規模と予測を収録しています。・世界の好酸球性喘息治療薬市場:売上、2018年-2023年、2024年-2029年
・世界の好酸球性喘息治療薬市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の好酸球性喘息治療薬市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「点滴静注型」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

好酸球性喘息治療薬のグローバル主要企業は、AstraZeneca、GSK、Genentech (Roche Group) & Novartis、Regeneron Pharmaceuticals & Sanofi、Teva Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、好酸球性喘息治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の好酸球性喘息治療薬市場:タイプ別、2018年-2023年、2024年-2029年
世界の好酸球性喘息治療薬市場:タイプ別市場シェア、2022年
・点滴静注型、皮下注射型

世界の好酸球性喘息治療薬市場:用途別、2018年-2023年、2024年-2029年
世界の好酸球性喘息治療薬市場:用途別市場シェア、2022年
・子供、大人、中高生

世界の好酸球性喘息治療薬市場:地域・国別、2018年-2023年、2024年-2029年
世界の好酸球性喘息治療薬市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における好酸球性喘息治療薬のグローバル売上、2018年-2023年
・主要企業における好酸球性喘息治療薬のグローバル売上シェア、2022年
・主要企業における好酸球性喘息治療薬のグローバル販売量、2018年-2023年
・主要企業における好酸球性喘息治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
AstraZeneca、GSK、Genentech (Roche Group) & Novartis、Regeneron Pharmaceuticals & Sanofi、Teva Pharmaceuticals

*************************************************************

・調査・分析レポートの概要
好酸球性喘息治療薬市場の定義
市場セグメント
世界の好酸球性喘息治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の好酸球性喘息治療薬市場規模
世界の好酸球性喘息治療薬市場規模:2022年 VS 2029年
世界の好酸球性喘息治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの好酸球性喘息治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の好酸球性喘息治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:点滴静注型、皮下注射型
好酸球性喘息治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:子供、大人、中高生
好酸球性喘息治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別好酸球性喘息治療薬市場規模 2022年と2029年
地域別好酸球性喘息治療薬売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
AstraZeneca、GSK、Genentech (Roche Group) & Novartis、Regeneron Pharmaceuticals & Sanofi、Teva Pharmaceuticals

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Eosinophilic Asthma Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Eosinophilic Asthma Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Eosinophilic Asthma Treatment Overall Market Size
2.1 Global Eosinophilic Asthma Treatment Market Size: 2022 VS 2029
2.2 Global Eosinophilic Asthma Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Eosinophilic Asthma Treatment Players in Global Market
3.2 Top Global Eosinophilic Asthma Treatment Companies Ranked by Revenue
3.3 Global Eosinophilic Asthma Treatment Revenue by Companies
3.4 Top 3 and Top 5 Eosinophilic Asthma Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Eosinophilic Asthma Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Eosinophilic Asthma Treatment Players in Global Market
3.6.1 List of Global Tier 1 Eosinophilic Asthma Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Eosinophilic Asthma Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Eosinophilic Asthma Treatment Market Size Markets, 2022 & 2029
4.1.2 Intravenous Infusion
4.1.3 Subcutaneous Injection
4.2 By Type – Global Eosinophilic Asthma Treatment Revenue & Forecasts
4.2.1 By Type – Global Eosinophilic Asthma Treatment Revenue, 2018-2023
4.2.2 By Type – Global Eosinophilic Asthma Treatment Revenue, 2024-2029
4.2.3 By Type – Global Eosinophilic Asthma Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Eosinophilic Asthma Treatment Market Size, 2022 & 2029
5.1.2 Children
5.1.3 Adults
5.1.4 Teenagers
5.2 By Application – Global Eosinophilic Asthma Treatment Revenue & Forecasts
5.2.1 By Application – Global Eosinophilic Asthma Treatment Revenue, 2018-2023
5.2.2 By Application – Global Eosinophilic Asthma Treatment Revenue, 2024-2029
5.2.3 By Application – Global Eosinophilic Asthma Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Eosinophilic Asthma Treatment Market Size, 2022 & 2029
6.2 By Region – Global Eosinophilic Asthma Treatment Revenue & Forecasts
6.2.1 By Region – Global Eosinophilic Asthma Treatment Revenue, 2018-2023
6.2.2 By Region – Global Eosinophilic Asthma Treatment Revenue, 2024-2029
6.2.3 By Region – Global Eosinophilic Asthma Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Eosinophilic Asthma Treatment Revenue, 2018-2029
6.3.2 US Eosinophilic Asthma Treatment Market Size, 2018-2029
6.3.3 Canada Eosinophilic Asthma Treatment Market Size, 2018-2029
6.3.4 Mexico Eosinophilic Asthma Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Eosinophilic Asthma Treatment Revenue, 2018-2029
6.4.2 Germany Eosinophilic Asthma Treatment Market Size, 2018-2029
6.4.3 France Eosinophilic Asthma Treatment Market Size, 2018-2029
6.4.4 U.K. Eosinophilic Asthma Treatment Market Size, 2018-2029
6.4.5 Italy Eosinophilic Asthma Treatment Market Size, 2018-2029
6.4.6 Russia Eosinophilic Asthma Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Eosinophilic Asthma Treatment Market Size, 2018-2029
6.4.8 Benelux Eosinophilic Asthma Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Eosinophilic Asthma Treatment Revenue, 2018-2029
6.5.2 China Eosinophilic Asthma Treatment Market Size, 2018-2029
6.5.3 Japan Eosinophilic Asthma Treatment Market Size, 2018-2029
6.5.4 South Korea Eosinophilic Asthma Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Eosinophilic Asthma Treatment Market Size, 2018-2029
6.5.6 India Eosinophilic Asthma Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Eosinophilic Asthma Treatment Revenue, 2018-2029
6.6.2 Brazil Eosinophilic Asthma Treatment Market Size, 2018-2029
6.6.3 Argentina Eosinophilic Asthma Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Eosinophilic Asthma Treatment Revenue, 2018-2029
6.7.2 Turkey Eosinophilic Asthma Treatment Market Size, 2018-2029
6.7.3 Israel Eosinophilic Asthma Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Eosinophilic Asthma Treatment Market Size, 2018-2029
6.7.5 UAE Eosinophilic Asthma Treatment Market Size, 2018-2029
7 Eosinophilic Asthma Treatment Companies Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Eosinophilic Asthma Treatment Major Product Offerings
7.1.4 AstraZeneca Eosinophilic Asthma Treatment Revenue in Global Market (2018-2023)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Eosinophilic Asthma Treatment Major Product Offerings
7.2.4 GSK Eosinophilic Asthma Treatment Revenue in Global Market (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 Genentech (Roche Group) & Novartis
7.3.1 Genentech (Roche Group) & Novartis Company Summary
7.3.2 Genentech (Roche Group) & Novartis Business Overview
7.3.3 Genentech (Roche Group) & Novartis Eosinophilic Asthma Treatment Major Product Offerings
7.3.4 Genentech (Roche Group) & Novartis Eosinophilic Asthma Treatment Revenue in Global Market (2018-2023)
7.3.5 Genentech (Roche Group) & Novartis Key News & Latest Developments
7.4 Regeneron Pharmaceuticals & Sanofi
7.4.1 Regeneron Pharmaceuticals & Sanofi Company Summary
7.4.2 Regeneron Pharmaceuticals & Sanofi Business Overview
7.4.3 Regeneron Pharmaceuticals & Sanofi Eosinophilic Asthma Treatment Major Product Offerings
7.4.4 Regeneron Pharmaceuticals & Sanofi Eosinophilic Asthma Treatment Revenue in Global Market (2018-2023)
7.4.5 Regeneron Pharmaceuticals & Sanofi Key News & Latest Developments
7.5 Teva Pharmaceuticals
7.5.1 Teva Pharmaceuticals Company Summary
7.5.2 Teva Pharmaceuticals Business Overview
7.5.3 Teva Pharmaceuticals Eosinophilic Asthma Treatment Major Product Offerings
7.5.4 Teva Pharmaceuticals Eosinophilic Asthma Treatment Revenue in Global Market (2018-2023)
7.5.5 Teva Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Eosinophilic Asthma Treatment Market Opportunities & Trends in Global Market
Table 2. Eosinophilic Asthma Treatment Market Drivers in Global Market
Table 3. Eosinophilic Asthma Treatment Market Restraints in Global Market
Table 4. Key Players of Eosinophilic Asthma Treatment in Global Market
Table 5. Top Eosinophilic Asthma Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Eosinophilic Asthma Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Eosinophilic Asthma Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Eosinophilic Asthma Treatment Product Type
Table 9. List of Global Tier 1 Eosinophilic Asthma Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Eosinophilic Asthma Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Eosinophilic Asthma Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Eosinophilic Asthma Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Eosinophilic Asthma Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Eosinophilic Asthma Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Eosinophilic Asthma Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Eosinophilic Asthma Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2024-2029
Table 30. AstraZeneca Company Summary
Table 31. AstraZeneca Eosinophilic Asthma Treatment Product Offerings
Table 32. AstraZeneca Eosinophilic Asthma Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. AstraZeneca Key News & Latest Developments
Table 34. GSK Company Summary
Table 35. GSK Eosinophilic Asthma Treatment Product Offerings
Table 36. GSK Eosinophilic Asthma Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. GSK Key News & Latest Developments
Table 38. Genentech (Roche Group) & Novartis Company Summary
Table 39. Genentech (Roche Group) & Novartis Eosinophilic Asthma Treatment Product Offerings
Table 40. Genentech (Roche Group) & Novartis Eosinophilic Asthma Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Genentech (Roche Group) & Novartis Key News & Latest Developments
Table 42. Regeneron Pharmaceuticals & Sanofi Company Summary
Table 43. Regeneron Pharmaceuticals & Sanofi Eosinophilic Asthma Treatment Product Offerings
Table 44. Regeneron Pharmaceuticals & Sanofi Eosinophilic Asthma Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Regeneron Pharmaceuticals & Sanofi Key News & Latest Developments
Table 46. Teva Pharmaceuticals Company Summary
Table 47. Teva Pharmaceuticals Eosinophilic Asthma Treatment Product Offerings
Table 48. Teva Pharmaceuticals Eosinophilic Asthma Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Teva Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Eosinophilic Asthma Treatment Segment by Type in 2022
Figure 2. Eosinophilic Asthma Treatment Segment by Application in 2022
Figure 3. Global Eosinophilic Asthma Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Eosinophilic Asthma Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Eosinophilic Asthma Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Eosinophilic Asthma Treatment Revenue in 2022
Figure 8. By Type - Global Eosinophilic Asthma Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Eosinophilic Asthma Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Eosinophilic Asthma Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Eosinophilic Asthma Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Eosinophilic Asthma Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Eosinophilic Asthma Treatment Revenue Market Share, 2018-2029
Figure 16. US Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Eosinophilic Asthma Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Eosinophilic Asthma Treatment Revenue Market Share, 2018-2029
Figure 28. China Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Eosinophilic Asthma Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Eosinophilic Asthma Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Eosinophilic Asthma Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. AstraZeneca Eosinophilic Asthma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. GSK Eosinophilic Asthma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Genentech (Roche Group) & Novartis Eosinophilic Asthma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Regeneron Pharmaceuticals & Sanofi Eosinophilic Asthma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Teva Pharmaceuticals Eosinophilic Asthma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



★調査レポート[世界の好酸球性喘息治療薬市場予測2023-2029:点滴静注型、皮下注射型] (コード:MMG23FB2472)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の好酸球性喘息治療薬市場予測2023-2029:点滴静注型、皮下注射型]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆